» Articles » PMID: 21996466

1-Aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide: an Effective Scaffold for the Design of Either CB1 or CB2 Receptor Ligands

Abstract

New 1-aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides were synthesized as cannabinoid (CB) receptor ligands. Compound 11 (CB(1)K(i) = 2.3 nM, CB(1) SI = 163.6) showed CB(1) receptor affinity and selectivity superior to Rimonabant and AM251. Acute administration of 2mg/kg 11 reduced sucrose, but not regular food, intake in rats. On the other hand, compound 23 (CB(2)K(i) = 0.51 nM, CB(2) SI = 30.0) showed significant affinity and selectivity for the CB(2) receptor. The results presented here show that the 1-aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide may serve as an effective scaffold for the design of either CB(1) or CB(2) receptor ligands.

Citing Articles

A deep learning framework combining molecular image and protein structural representations identifies candidate drugs for pain.

Yang Y, Qiu Y, Hu J, Rosen-Zvi M, Guan Q, Cheng F Cell Rep Methods. 2024; 4(10):100865.

PMID: 39341201 PMC: 11573792. DOI: 10.1016/j.crmeth.2024.100865.


General Synthesis of -1,4-Dialdehydes and Their Application in Ir-Catalyzed Asymmetric Tishchenko Reactions.

Zhao R, Ismiyarto , Zhou D, Asano K, Suzuki T, Sasai H ACS Omega. 2024; 9(16):17945-17955.

PMID: 38680320 PMC: 11044153. DOI: 10.1021/acsomega.3c09381.


Rimonabant-Based Compounds Bearing Hydrophobic Amino Acid Derivatives as Cannabinoid Receptor Subtype 1 Ligands.

Dvoracsko S, Dimmito M, Sebastiani J, La Regina G, Silvestri R, Pieretti S ACS Med Chem Lett. 2023; 14(4):479-486.

PMID: 37077391 PMC: 10108392. DOI: 10.1021/acsmedchemlett.3c00024.